Skip to main content
    • Aa
    • Aa

Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs

  • M. J. DOENHOFF (a1), P. HAGAN (a2), D. CIOLI (a3), V. SOUTHGATE (a4), L. PICA-MATTOCCIA (a3), S. BOTROS (a5), G. COLES (a6), L. A. TCHUEM TCHUENTÉ (a7), A. MBAYE (a8) and D. ENGELS (a9)...

Treatment with praziquantel (PZQ) has become virtually the sole basis of schistosomiasis control in sub-Saharan Africa and elsewhere, and the drug is reviewed here in the context of the increasing rate that it is being used for this purpose. Attention is drawn to our relative lack of knowledge about the mechanisms of action of PZQ at the molecular level, the need for more work to be done on schistosome isolates that have been collected recently from endemic areas rather than those maintained in laboratory conditions for long periods, and our reliance for experimental work mainly on Schistosoma mansoni, little work having been done on S. haematobium. There is no evidence that resistance to PZQ has been induced in African schistosomes as a result of its large-scale use on that continent to date, but there is also no assurance that PZQ and/or schistosomes are in any way unique and that resistant organisms will not be selected as a result of widespread drug usage. The failure of PZQ to produce complete cures in populations given a routine treatment should therefore solicit considerable concern. With few alternatives to PZQ currently available and/or on the horizon, methods to monitor drug-susceptibility in African schistosomes need to be devised and used to help ensure that this drug remains effective for as long a time as possible.

Corresponding author
*Corresponding author: Michael J. Doenhoff, School of Biology, University of Nottingham, University Park, NottinghamNG7 2RD, UK. Tel: +44 1115 951-3304; Fax: +44 115 951-3251; E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

M. H. Abdulla , K. C. Lim , M. Sajid , J. H. Mckerrow and C. R. Caffrey (2007). Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Medicine 4, e14.

H. E. Allen , D. W. T. Crompton , N. de Silva , P. T. LoVerde and G. R. Olds (2002). New policies for using anthelmintics in high risk groups. Trends in Parasitology 18, 381382.

L. Pica-Mattoccia , M. J. Doenhoff , C. Valle , A. Basso , A.-R. Troiani , P. Liberti , A. Festucci , A. Guidi and D. Cioli (2009). Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni. Acta Tropica (In Press). doi:10.1016/j.actatropica.2009.01.012.

F. Badria , G. Abou-Mohamed , A. El-Mowafy , A. Masoud and O. Salama (2001). Mirazid: a new schistosomicidal drug. Pharmaceutical Biology 39, 127131.

P. Barduagni , Y. Hassanein , M. Mohamed , A. El Wakeel , M. El Sayed , Z. Hallaj and F. Curtale (2008). Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governate, Egypt. Parasitology Research 102, 631633.

S. Botros and J. L. Bennett (2007). Praziquantel resistance. Expert Opinion on Drug Discovery 2, 535540.

S. S. Botros , O. A. Hammmam , S. H. El-Lakhany , S. H. Seif el-Din and F. A. Ebeid (2008). Schistosoma haematobium (Egyptian strain): rate of development and effect of praziquantel treatment. Journal of Parasitology 94, 386394.

S. Botros , L. Pica-Mattoccia , S. William , N. El-Lakkani and D. Cioli (2005 a). Effect of praziquantel on the immature stages of Schistosoma haematobium. International Journal for Parasitology 35, 14531457.

S. Botros , H. Sayed , N. Amer , M. El-Ghannam , J. L. Bennett and T. A. Day (2005 b). Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. International Journal for Parasitology 35, 787791.

M. A. Brady , P. J. Hooper and E. A. Ottesen (2006). Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends in Parasitology 22, 285291.

D. Cioli , S. S. Botros , K. Wheatcroft-Francklow , A. Mbaye , V. Southgate , L. A. Tchuem Tchuenté , L. Pica-Mattoccia , A. R. Troiani , S. H. El-Din , A. N. Sabra , J. Albin , D. Engels and M. J. Doenhoff (2004). Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates. International Journal for Parasitology 34, 979987.

D. Cioli , L. Pica-Mattoccia and S. Archer (1995). Antischistosomal drugs: past, present … and future? Pharmacology and Therapeutics 68, 3585.

D. Cioli , C. Valle , F. Angelucci and A. Miele (2008). Will new antischistosomal drugs finally emerge? Trends in Parasitology 24, 379382.

G. C. Coles , W. T. Mutahi , G. K. Kinoti , J. I. Bruce and N. Katz (1987). Tolerance of Kenyan Schistosoma mansoni to oxamniquine. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 782785.

I. M. Da Silva , R. Thiengo , M. J. Conceicao , L. Rey , H. L. Lenzi , E. P. Filho and P. C. Ribeiro (2005). Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Memorias do Instituto Oswaldo Cruz 100, 445449.

M. J. Doenhoff (1998). Is schistosomicidal chemotherapy sub-curative? Implications for drug resistance. Parasitology Today 14, 434435.

M. J. Doenhoff , D. Cioli and J. Utzinger (2008). Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Current Opinion in Infectious Diseases 21, 659667.

M. J. Doenhoff and L. Pica-Mattoccia (2006). Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Reviews in Anti-Infective Therapy 4, 199210.

M. J. Doenhoff , A. A. Sabah , C. Fletcher , G. Webbe and J. Bain (1987). Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 947951.

D. Engels , L. Chitsulo , A. Montresor and L. Savioli (2002). The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica 82, 139146.

P. G. Fallon , J. S. Mubarak , R. E. Fookes , M. Niang , A. E. Butterworth , R. F. Sturrock and M. J. Doenhoff (1997). Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Experimental Parasitology 86, 2936.

A. Fenwick (2006). New initiatives against Africa's worms. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 200207.

A. Fenwick , L. Savioli , D. Engels , R. N. Bergquist and M. H. Todd (2003). Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends in Parasitology 19, 509515.

B. Gryseels , A. Mbaye , S. J. de Vlas , F. F. Stelma , F. Guisse , L. Van Lieshout , D. Faye , M. Diop , A. Ly , L. A. Tchuem-Tchuente , D. Engels and K. Polman (2001). Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health 6, 864873.

P. Hagan , C. C. Appleton , G. C. Coles , J. R. Kusel and L. A. Tchuem-Tchuente (2004). Schistosomiasis control: keep taking the tablets. Trends in Parasitology 20, 9297.

P. J. Hotez , D. H. Molyneux , A. Fenwick , J. Kumaresan , S. Ehrlich Sachs , J. D. Sachs and L. Savioli (2007). Control of neglected tropical diseases. New England Journal of Medicine 357, 10181027.

M. C. Jeziorski and R. M. Greenberg (2006). Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. International Journal for Parasitology 36, 625632.

M. V. Johansen , M. Sacko , B. J. Vennervald and N. B. Kabatereine (2007). Leave children untreated and sustain inequity! Trends in Parasitology 23, 568569.

N. B. Kabatereine , J. Kemijumbi , J. H. Ouma , R. F. Sturrock , A. E. Butterworth , H. Madsen , N. Ornbjerg , D. W. Dunne and B. J. Vennnervald (2003). Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 599603.

N. Katz and P. M. Coelho (2008). Clinical therapy of schistosomiasis mansoni: the Brazilian contribution. Acta Tropica 108, 7278.

J. Keiser , J. Chollet , S. H. Xiao , J. Y. Mei , P. Y. Jiao , J. Utzinger and M. Tanner (2009). Mefloquine – an amionoalcohol with promising antischistosomal properties in mice. PLoS Neglected Tropical Diseases 3, e350.

J. Keiser and J. Utzinger (2007). Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Current Opinion in Infectious Diseases 20, 605612.

C. H. King and M. Dangerfield-Cha (2008). The unacknowledged impact of chronic schistosomiasis. Chronic Illness 4, 6579.

C. H. King , K. Dickman and D. J. Tisch (2005). Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365, 15611569.

A. N. Kuntz , E. Davioud-Charvet , A. A. Sayed , L. L. Califf , J. Dessolin , E. S. J. Arner and D. L. Williams (2007). Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PloS Medicine 4, e206.

P. J. Lammie , A. Fenwick and J. Utzinger (2006). A blueprint for success: integration of neglected tropical disease control programmes. Trends in Parasitology 22, 313321.

J. Li , Y. Wang , A. Fenwick , T. A. Clayton , Y. Y. K. Lau , C. Legido-Quigley , J. C. Lindon , J. Utzinger and E. Holmes (2007). A high-performance liquid chromatography and nuclear magnetic resonance spectroscopy-based analysis of commercially available praziquantel tablets. Journal of Pharmaceutical and Biomedical Analysis 45, 263267.

P. T. LoVerde , J. Dewald , D. J. Minchella , S. C. Bosshardt and R. T. Damian (1985). Evidence for host-induced selection in Schistosoma mansoni. Journal of Parasitology 71, 297301.

T. Meyer , H. Seklijc , S. Fuchs , H. Bothe , D. Schollmeyer and C. Miculka (2009). Taste, a new incentive to switch to (R) praziquantel in schistosomiasis treatment. PLoS Neglected Tropical Diseases 3: e357.

R. Montero and P. Ostrosky (1997). Genotoxic activity of praziquantel. Mutation Research 387, 123139.

A. Montresor , P. Odermatt , S. Muth , F. Iwata , Y. A. Raja'a , A. M. Assis , A. Zulkifli , N. B. Kabatereine , A. Fenwick , S. Al-Awaidy , H. Allen , D. Engels and L. Savioli (2005). The WHO dose pole for the administration of praziquantel is also accurate in non-African populations. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 7881.

C. O'Boyle , R. Lambe and A. Darragh (1985). Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam. European Journal of Clinical Pharmacology 29, 105108.

C. Pereira , P. G. Fallon , J. Cornette , A. Capron , M. J. Doenhoff and R. J. Pierce (1998). Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni. Parasitology 117, 6373.

L. Pica-Mattoccia , D. Carlini , A. Guidi , V. Cimica , F. Vigorosi and D. Cioli (2006). The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase. Memorias do Instituto Oswaldo Cruz 101, 307312.

L. Pica-Mattoccia and D. Cioli (2004). Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. International Journal for Parasitology 34, 527533.

L. Pica-Mattoccia , T. Orsini , A. Basso , A. Festucci , P. Liberti , A. Guidi , A. L. Marcatto-Maggi , S. Nobre-Santana , A. R. Troiani , D. Cioli and C. Valle (2008). Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death. Experimental Parasitology 119, 332335.

L. Pica-Mattoccia , C. Valle , A. Basso , A. R. Troiani , F. Vigorosi , P. Liberti , A. Festucci and D. Cioli (2007 b). Cytochalasin D abolishes the schistosomicidal activity of praziquantel. Experimental Parasitology 115, 344351.

M. Picquet , J. Vercruysse , D. J. Shaw , M. Diop and A. Ly (1998). Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 9093.

E. Renganathan and D. Cioli (1998). An international initiative on praziquantel use. Parasitology Today 14, 390391.

A. A. Sabah , C. Fletcher , G. Webbe and M. J. Doenhoff (1986). Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology 61, 294303.

A. Simeonov , A. Jadhav , A. A. Sayed , Y. Wang , M. E. Nelson , C. J. Thomas , J. Inglese , D. L. Williams and C. P. Austin (2008). Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS Neglected Tropical Diseases 2, e127.

F. F. Stelma , S. Sall , B. Daff , S. Sow , M. Niang and B. Gryseels (1997). Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. Journal of Infectious Diseases 176, 304307.

J. R. Stothard and A. F. Gabrielli (2007 a). Schistosomiasis in African infants and preschool children: to treat or not to treat. Trends in Parasitology 23, 8386.

J. R. Stothard and A. F. Gabrielli (2007 b). Response to Johansen et al.: Leave children untreated and sustain inequity! Trends in Parasitology 23, 569570.

S. M. Sulaiman , M. Traore , D. Engels , P. Hagan and D. Cioli (2001). Counterfeit praziquantel. Lancet 358, 666667.

H. Tallima and R. El Ridi (2007). Praziquantel binds Schistosoma mansoni adult worm actin. International Journal of Antimicrobial Agents 29, 570575.

L. A. Tchuem Tchuente , V. R. Southgate , A. Mbaye , D. Engels and B. Gryseels (2001). The efficacy of praziquantel against Schistosoma mansoni infection in Ndombo, northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 6566.

A. R. Troiani , L. Pica-Mattoccia , C. Valle , D. Cioli , G. Mignogna , F. Ronketti and M. Todd (2007). Is actin the praziquantel receptor? International Journal of Antimicrobial Agents 30, 280281.

M. H. Tsai , K. A. Marx , M. M. Ismail and L. Tao (2000). Randomly amplified polymorphic DNA (RAPD) polymerase chain reaction assay for identification of Schistosoma mansoni strains sensitive or tolerant to anti-schistosomal drugs. Journal of Parasitology 86, 146149.

J. Utzinger , E. K. N'Goran , A. N'Dri , C. Lengeler and M. Tanner (2000 a). Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Tropical Medicine and International Health 5, 771778.

J. Utzinger , E. K. N'Goran , A. N'Dri , C. Lengeler , S. H. Xiao and M. Tanner (2000 b). Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355, 13201325.

C. Valle , A. R. Troiani , A. Festucci , L. Pica-Mattoccia , P. Liberti , A. Wolstenholme , K. Francklow , M. J. Doenhoff and D. Cioli (2003). Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel. Molecular and Biochemical Parasitology 130, 111115.

M. J. van Der Werf , S. J. de Vlas , S. Brooker , C. W. N. Looman , N. J. D. Nagelkerke , J. D. F. Habbema and D. Engels (2003). Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Tropica 86, 125139.

S. William , A. Sabra , F. Ramzy , M. Mousa , Z. Demerdash , J. L. Bennett , T. A. Day and S. Botros (2001). Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. International Journal for Parasitology 31, 10931100.

L. Van Nassauw , S. Toovey , J. Van Op den Bosch , J.-P. Timmermans and J. Vercruysse (2008). Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. Travel Medicine and Infectious Diseases 6, 253258.

S. H. Xiao , J. Keiser , J. Chollet , J. Utzinger , Y. Dong , J. L. Vennerstrom and M. Tanner (2007). In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrobial Agents and Chemotherapy 51, 14401445.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

  • ISSN: 0031-1820
  • EISSN: 1469-8161
  • URL: /core/journals/parasitology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 3
Total number of PDF views: 44 *
Loading metrics...

Abstract views

Total abstract views: 283 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 25th May 2017. This data will be updated every 24 hours.